RESMED INC — Director's Dealing 2024

Nov 27, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2024-11-25

Reporting Person: FARRELL PETER C (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-11-25	ResMed Common Stock Options	$249.56	A	1468	Acquired	2031-11-25	ResMed Common Stock (1468)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	83218	Direct

Footnotes

F1: Represents date options first became exercisable. Options vest on the earlier of (i) the first November 11 following the Grant Date, or (ii) the date of the first (1st) annual meeting of stockholders of the Company following the Grant Date.